Literature DB >> 31832846

A noncanonical binding site of linezolid revealed via molecular dynamics simulations.

G I Makarov1, T M Makarova2,3.   

Abstract

Linezolid, an antibiotic of oxazolidinone family, is a translation inhibitor. The mechanism of its action that consists in preventing the binding of aminoacyl-tRNA to the A-site of the large subunit of a ribosome was embraced on the basis of the X-ray structural analysis of the linezolid complexes with vacant bacterial ribosomes. However, the known structures of the linezolid complexes with bacterial ribosomes poorly explain the linezolid selectivity in suppression of protein biosynthesis, depending on the amino acid sequence of the nascent peptide. In the present study the most probable structure of the linezolid complex with a E. coli ribosome in the A,A/P,P-state that is in line with the results of biochemical studies of linezolid action has been obtained by molecular dynamics simulation methods.

Entities:  

Keywords:  Antibiotics; Linezolid; Molecular dynamics; Ribosome; Simulation

Mesh:

Substances:

Year:  2019        PMID: 31832846     DOI: 10.1007/s10822-019-00269-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  43 in total

1.  Bias-Exchange Metadynamics Simulations: An Efficient Strategy for the Analysis of Conduction and Selectivity in Ion Channels.

Authors:  Carmen Domene; Paolo Barbini; Simone Furini
Journal:  J Chem Theory Comput       Date:  2015-04-14       Impact factor: 6.006

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

3.  Side-chain recognition and gating in the ribosome exit tunnel.

Authors:  Paula M Petrone; Christopher D Snow; Del Lucent; Vijay S Pande
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

4.  The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin.

Authors:  A H Lin; R W Murray; T J Vidmar; K R Marotti
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  Identification of two Escherichia coli pseudouridine synthases that show multisite specificity for 23S RNA.

Authors:  L Huang; J Ku; M Pookanjanatavip; X Gu; D Wang; P J Greene; D V Santi
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

6.  The methyltransferase YfgB/RlmN is responsible for modification of adenosine 2503 in 23S rRNA.

Authors:  Seok-Ming Toh; Liqun Xiong; Taeok Bae; Alexander S Mankin
Journal:  RNA       Date:  2007-11-19       Impact factor: 4.942

7.  The rluC gene of Escherichia coli codes for a pseudouridine synthase that is solely responsible for synthesis of pseudouridine at positions 955, 2504, and 2580 in 23 S ribosomal RNA.

Authors:  J Conrad; D Sun; N Englund; J Ofengand
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

8.  Lennard-Jones Lattice Summation in Bilayer Simulations Has Critical Effects on Surface Tension and Lipid Properties.

Authors:  Christian L Wennberg; Teemu Murtola; Berk Hess; Erik Lindahl
Journal:  J Chem Theory Comput       Date:  2013-07-09       Impact factor: 6.006

9.  Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations.

Authors:  In Suk Joung; Thomas E Cheatham
Journal:  J Phys Chem B       Date:  2008-07-02       Impact factor: 2.991

10.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools.

Authors:  Christian Quast; Elmar Pruesse; Pelin Yilmaz; Jan Gerken; Timmy Schweer; Pablo Yarza; Jörg Peplies; Frank Oliver Glöckner
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

View more
  1 in total

1.  Triphenilphosphonium Analogs of Chloramphenicol as Dual-Acting Antimicrobial and Antiproliferating Agents.

Authors:  Julia A Pavlova; Zimfira Z Khairullina; Andrey G Tereshchenkov; Pavel A Nazarov; Dmitrii A Lukianov; Inna A Volynkina; Dmitry A Skvortsov; Gennady I Makarov; Etna Abad; Somay Y Murayama; Susumu Kajiwara; Alena Paleskava; Andrey L Konevega; Yuri N Antonenko; Alex Lyakhovich; Ilya A Osterman; Alexey A Bogdanov; Natalia V Sumbatyan
Journal:  Antibiotics (Basel)       Date:  2021-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.